Situation: A 48-year-old woman weighing 60 kg returns to the surgical ward after an open abdominal operation under general anesthesia. She has an indwelling urinary catheter and a wound drain. Her preoperative blood pressure was 126/80 mmHg and her heart rate was 80/min. Her daughter stays with her as a watcher. Several antiemetics are available for postoperative nausea and vomiting. Which one is contraindicated when a mechanical bowel obstruction is present?

Metoclopramide stimulates gastrointestinal motility and speeds gastric emptying, so it is contraindicated in mechanical bowel obstruction, perforation, or bleeding. The other antiemetics act on vomiting pathways without pushing the bowel against a blockage.

Why metoclopramide is the contraindicated antiemetic

A mechanical bowel obstruction means the intestinal lumen is physically blocked, so peristaltic waves cannot move contents forward. In this situation, any drug that increases gastrointestinal motility can raise intraluminal pressure proximal to the blockage, worsening distension, ischemia, and the risk of perforation. Metoclopramide is a prokinetic agent that enhances gastric emptying and small bowel transit, making it unsafe when a mechanical obstruction is present. Its dopamine D2 receptor antagonism and 5-HT4 agonism drive this motility effect, which is the exact opposite of what an obstructed bowel needs.

The other options do not push the bowel against a blockage. Transdermal scopolamine is an antimuscarinic that reduces acetylcholine-driven smooth muscle contraction and also acts on the vestibular and central vomiting pathways. Ondansetron is a 5-HT3 receptor antagonist that blocks serotonin-mediated vagal afferent signaling to the chemoreceptor trigger zone and vomiting center, without stimulating peristalsis. Dexamethasone suppresses inflammation and edema around a tumor or bowel wall, and it modulates central emetic pathways, but it does not directly increase motility. Key point! The contraindication is specific to the prokinetic mechanism, not to antiemetic efficacy.

Drug	Primary antiemetic mechanism	Effect on GI motility	Safe in mechanical obstruction?
Metoclopramide	D2 antagonist, 5-HT4 agonist, 5-HT3 antagonist	Increases gastric emptying and small bowel transit	No — contraindicated
Transdermal scopolamine	Muscarinic antagonist, central vestibular suppression	Decreases or neutral	Yes
Ondansetron	5-HT3 antagonist at vagal afferents and CTZ	Neutral	Yes
Dexamethasone	Anti-inflammatory, central emetic pathway modulation	Neutral	Yes

In malignant bowel obstruction, symptom management focuses on reducing secretions, inflammation, and central nausea rather than forcing motility. Prokinetic agents such as metoclopramide are avoided because they can convert a partial obstruction into a complete one or precipitate perforation. Antisecretory and anti-inflammatory approaches, along with centrally acting antiemetics, are preferred when the obstruction cannot be relieved mechanically. Watch out! Metoclopramide is also contraindicated in suspected gastrointestinal perforation or hemorrhage for the same reason: increased motility worsens the underlying structural injury.

For a postoperative patient with an open abdominal procedure, the nurse must assess for signs of ileus versus mechanical obstruction before administering any prokinetic. Bowel sounds, distension, nausea, vomiting, and the character of nasogastric or drain output help differentiate the two. A functional ileus may respond to prokinetics, but a mechanical obstruction requires decompression and surgical evaluation, not motility stimulation. The presence of a wound drain and indwelling catheter does not change this contraindication; the decision rests on the underlying bowel pathology.